Literature DB >> 6697399

Influence of interferon on human monocyte to macrophage development.

S Becker.   

Abstract

The effect of interferon-alpha (Wellferon) on human monocyte to macrophage maturation in vitro has been investigated. Cell volume and three markers, acid phosphatase, leucine aminopeptidase, and phagocytosis, which increase with maturation, have been studied employing recently developed flow cytofluorometric techniques. The increase in cell volume and in the expression of all three markers was inhibited in a dose-dependent manner in monocyte cultures given 50-300 U/ml of interferon within 2 hr of culture initiation. An initial dose of 300 U/ml of interferon, removed from the cultures after 24 hr, was as effective in inhibiting the development of each of the markers as three 100 U pulses on three consecutive days, and as effective as 300 U interferon left in throughout the culture period. Histogram analysis of marker expression indicated that all monocytes, and not a subpopulation, were affected by the interferon. Cytotoxic activity of freshly isolated monocytes rapidly decayed when the cells were cultured under standard maturation conditions. The addition of interferon to the cultures prevented the loss of this activity while also preventing the development of more mature cells. It appears that maintenance of the cytotoxic state is one influence of interferons; however, it may be that these cells have also been directed toward alternate pathways of macrophage differentiation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6697399     DOI: 10.1016/0008-8749(84)90085-6

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  12 in total

1.  Activation of human monocytes/macrophages by hypo-osmotic shock.

Authors:  O Frenkel; E Shani; I Ben-Bassat; F Brok-Simoni; E Shinar; D Danon
Journal:  Clin Exp Immunol       Date:  2001-04       Impact factor: 4.330

2.  The effect of interferons on cellular differentiation.

Authors:  T Moritz; H Kirchner
Journal:  Blut       Date:  1986-11

3.  Impaired monocyte-to-macrophage maturation in patients with lymphadenopathy syndrome.

Authors:  J Offenberger; T Lieu; O Frick; A J Ammann
Journal:  J Clin Immunol       Date:  1986-11       Impact factor: 8.317

4.  Cytokines in health and disease.

Authors:  L Borecký
Journal:  World J Microbiol Biotechnol       Date:  1992-12       Impact factor: 3.312

5.  Lentivirus-induced interferon inhibits maturation and proliferation of monocytes and restricts the replication of caprine arthritis-encephalitis virus.

Authors:  M C Zink; O Narayan
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

6.  Enhancement of defective monocyte function during immunotherapy with recombinant interferon.

Authors:  H Nielsen; P Ernst
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

7.  Activated macrophages for treating skin ulceration: gene expression in human monocytes after hypo-osmotic shock.

Authors:  O Frenkel; E Shani; I Ben-Bassat; F Brok-Simoni; G Rozenfeld-Granot; G Kajakaro; G Rechavi; N Amariglio; E Shinar; D Danon
Journal:  Clin Exp Immunol       Date:  2002-04       Impact factor: 4.330

8.  Interferon-gamma enhances monocyte cytotoxicity via enhanced reactive oxygen intermediate production. Absence of an effect on macrophage cytotoxicity is due to failure to enhance reactive nitrogen intermediate production.

Authors:  J H Martin; S W Edwards
Journal:  Immunology       Date:  1994-04       Impact factor: 7.397

9.  Comparison of retroviral p15E-related factors and interferon alpha in head and neck cancer.

Authors:  P J Simons; R A Oostendorp; M P Tas; H A Drexhage
Journal:  Cancer Immunol Immunother       Date:  1994-03       Impact factor: 6.968

10.  Measles virus infection of unstimulated blood mononuclear cells in vitro: antigen expression and virus production preferentially in monocytes.

Authors:  R Salonen; J Ilonen; A Salmi
Journal:  Clin Exp Immunol       Date:  1988-02       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.